208 related articles for article (PubMed ID: 17891598)
1. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
Eskandar MA
Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
[TBL] [Abstract][Full Text] [Related]
2. GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial.
Bellver J; Labarta E; Bosch E; Melo MA; Vidal C; Remohí J; Pellicer A
Fertil Steril; 2010 Aug; 94(3):1065-71. PubMed ID: 19501354
[TBL] [Abstract][Full Text] [Related]
3. Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.
Schachter M; Friedler S; Ron-El R; Zimmerman AL; Strassburger D; Bern O; Raziel A
Fertil Steril; 2008 Oct; 90(4):1087-93. PubMed ID: 18023439
[TBL] [Abstract][Full Text] [Related]
4. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles.
Karlström PO; Bergh T; Lundkvist O
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):37-42. PubMed ID: 10646814
[TBL] [Abstract][Full Text] [Related]
5. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
[TBL] [Abstract][Full Text] [Related]
6. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
[TBL] [Abstract][Full Text] [Related]
7. Impact of luteal phase support on pregnancy rates in intrauterine insemination cycles: a prospective randomized study.
Erdem A; Erdem M; Atmaca S; Guler I
Fertil Steril; 2009 Jun; 91(6):2508-13. PubMed ID: 18692788
[TBL] [Abstract][Full Text] [Related]
8. Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles.
Griesinger G; Kolibianakis EM; Papanikolaou EG; Diedrich K; Van Steirteghem A; Devroey P; Ejdrup Bredkjaer H; Humaidan P
Fertil Steril; 2007 Sep; 88(3):616-21. PubMed ID: 17451691
[TBL] [Abstract][Full Text] [Related]
9. Luteal phase support may improve pregnancy outcomes during intrauterine insemination cycles.
Maher MA
Eur J Obstet Gynecol Reprod Biol; 2011 Jul; 157(1):57-62. PubMed ID: 21514032
[TBL] [Abstract][Full Text] [Related]
10. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T
Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
[TBL] [Abstract][Full Text] [Related]
11. Outcome of frozen-thawed blastocysts derived from gonadotropin releasing hormone agonist or antagonist cycles.
Medved R; Virant-Klun I; Meden-Vrtovec H; Tomazevic T
J Assist Reprod Genet; 2006 Jun; 23(6):275-9. PubMed ID: 16823629
[TBL] [Abstract][Full Text] [Related]
12. Poor success of gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination for older women.
Harris ID; Missmer SA; Hornstein MD
Fertil Steril; 2010 Jun; 94(1):144-8. PubMed ID: 19394605
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
[TBL] [Abstract][Full Text] [Related]
14. [Differing response to GnRH antagonists in cycles of ovarian hyperstimulation plus intrauterine insemination].
Barros-Delgadillo JC; Trejo-Castañeda H; E-Ormsby C; Gaviño-Gaviño F
Ginecol Obstet Mex; 2010 Jan; 78(1):15-28. PubMed ID: 20931799
[TBL] [Abstract][Full Text] [Related]
15. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.
Kahraman K; Berker B; Atabekoglu CS; Sonmezer M; Cetinkaya E; Aytac R; Satiroglu H
Fertil Steril; 2009 Jun; 91(6):2437-44. PubMed ID: 18555238
[TBL] [Abstract][Full Text] [Related]
16. GnRH agonist versus GnRH antagonist in ovarian stimulation: the influence of body mass index on in vitro fertilization outcome.
Rabinson J; Meltcer S; Zohav E; Gemer O; Anteby EY; Orvieto R
Fertil Steril; 2008 Feb; 89(2):472-4. PubMed ID: 17582402
[TBL] [Abstract][Full Text] [Related]
17. Clomiphene citrate intrauterine insemination (IUI) before gonadotropin IUI affects the pregnancy rate and the rate of high-order multiple pregnancies.
Dickey RP; Taylor SN; Lu PY; Sartor BM; Pyrzak R
Fertil Steril; 2004 Mar; 81(3):545-50. PubMed ID: 15037400
[TBL] [Abstract][Full Text] [Related]
18. Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes.
Weitzman VN; Engmann L; DiLuigi A; Maier D; Nulsen J; Benadiva C
Fertil Steril; 2009 Jul; 92(1):226-30. PubMed ID: 18675961
[TBL] [Abstract][Full Text] [Related]
19. To add GnRH antagonists to controlled ovarian stimulation in management of subfertile couples with IUI may not have additional effect in terms of clinical pregnancy rates.
Kelekci S
Fertil Steril; 2011 Aug; 96(2):e133; author reply e134. PubMed ID: 21669412
[No Abstract] [Full Text] [Related]
20. Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination.
Díaz I; Guillén A; Pacheco A; Requena A; Garcia-Velasco JA
J Reprod Med; 2008 Jan; 53(1):33-9. PubMed ID: 18251359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
